Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (OTCPK:AMPE)

Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA Approval of Optina(TM), an Oral Treatment for Diabetic Macular Edema (DME)

PR Newswire October 14, 2015

AMPIO Receives Special Protocol Assessment (SPA) from the FDA and Commences Second Phase III pivotal trial of Ampion(TM)

PR Newswire September 22, 2015

Ampio Hosts Investor Call to Discuss Updates on Ampion(TM) and Optina(TM)

PR Newswire July 17, 2015

Ampio Announces Investor Call on Thursday, July 16, 4:30 p.m. EDT

PR Newswire July 9, 2015

24-Hour Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of July 7 Deadline in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. Investors

Business Wire July 6, 2015

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Advises Shareholders to Contact the Firm Prior to the Lead Plaintiff Deadline

Business Wire July 3, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2015 -- AMPE

GlobeNewswire July 1, 2015

INVESTOR ALERT: Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. Announced by Glancy Prongay & Murray LLP

Business Wire July 1, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE

PR Newswire June 26, 2015

Ampio Pharmaceuticals Announces Additional Statistically Significant Study Results for Optina(TM) in the Treatment of Diabetic Macular Edema (DME)

PR Newswire June 22, 2015

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Ampio Pharmaceuticals, Inc. Of Upcoming Deadline

Business Wire June 18, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 10, 2015 -- AMPE

GlobeNewswire June 16, 2015

Ampio Pharmaceuticals Provides Information on the Formation and Significance of Aytu BioScience to Ampio Shareholders

PR Newswire June 16, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Ampio Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit

Business Wire June 15, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE

GlobeNewswire June 13, 2015

TRADING ALERT: The Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important July 7, 2015 Deadline - AMPE

GlobeNewswire June 12, 2015

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Ampio Pharmaceuticals, Inc. (AMPE) to Contact the Firm

Marketwired June 12, 2015

AMPE INVESTOR ALERT: Investigation of Ampio Pharmaceuticals, Inc. Announced by Glancy Prongay & Murray LLP

Business Wire June 10, 2015

Ampio Pharmaceuticals Reports the Synergistic Effects of Ampion(TM) in the Treatment of Osteoarthritis of the Knee in Three Peer-reviewed Publications

PR Newswire June 9, 2015

INVESTOR ALERT: Investigation of Ampio Pharmaceuticals, Inc. Announced by The Law Offices of Howard G. Smith

Business Wire June 5, 2015